Bottling structure for preparing taurine buccal tablets
By adopting a bottling structure combining multiple channels and dual output ports, and a baffle plate driven by a baffle cylinder in the production of taurine tablets, the problem of blockage during bottling was solved, achieving continuous production and efficient bottling.
Patent Information
- Application Number
- CN202422482310.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Utility models(China)
- Current Assignee / Owner
- Filing Date
- 2024-10-15
- Publication Date
- 2025-11-04
- Estimated Expiration
- 2034-10-15
AI Technical Summary
The existing taurine tablet production and bottling process is prone to blockages, leading to downtime and affecting processing efficiency.
The system employs a structure combining multiple longitudinally arranged bottling channels with two lozenge output ports. Each bottling channel has a first baffle assembly at its lower end and a second baffle assembly at its upper end. The baffle plates are dynamically adjusted by a cylinder to prevent blockage, and the system is equipped with a three-stage vibrating feeder for lozenge conveying.
This technology enables channel switching without stopping the machine during bottling, ensuring continuous production, improving work efficiency, and avoiding downtime caused by blockages.
Smart Images

Figure CN223508530U_ABST
Abstract
Description
Technical Field
[0001] This utility model relates to a bottling structure for the preparation of taurine tablets. Background Technology
[0002] Currently, with consumers' increasing focus on health and nutrition, taurine, as an amino acid with multiple physiological functions, is finding wider applications in food, medicine, and other fields. For convenience, taurine is now being produced as lozenges. However, existing taurine lozenge production and bottling processes typically employ a single bottling channel. This means the produced taurine lozenges continuously fall into the bottling channel and into the packaging bottle located below it. This single-channel bottling method is prone to blockages, requiring machine shutdown and manual removal, thus impacting overall processing efficiency. Utility Model Content
[0003] This invention addresses the problems existing in the prior art by providing a bottling structure for the preparation of taurine tablets.
[0004] To achieve the above objectives, the technical solution adopted by this utility model is as follows: a bottling structure for preparing taurine tablets, comprising a conveyor belt for longitudinally conveying vertically placed packaging bottles, a bottling box being disposed directly above the conveyor belt, and multiple longitudinally arranged bottling channels being disposed inside the bottling box, the bottling channels extending vertically; multiple tablet drop inlets corresponding to the positions of the multiple bottling channels being disposed at the top of the bottling box, the tablet drop inlets being connected to the corresponding bottling channels, and a first baffle assembly being disposed at the lower end of each bottling channel; and two longitudinally arranged tablet output ports being disposed at the lower end of the bottling box, each tablet output port being simultaneously connected to several bottling channels, and a second baffle assembly being disposed within each tablet output port.
[0005] Furthermore, there are eight bottling channels, four of which share one tablet output port, and the other four bottling channels share another tablet output port.
[0006] Furthermore, the lower end of the bottling box is inverted conical in shape, and an output tube is provided in the middle of the bottom surface of the bottling box, with two tablet output ports located inside the output tube.
[0007] Furthermore, each bottling channel has a first slot extending laterally on its lower sidewall; the first baffle assembly includes a first baffle plate that slides through the first slot, the first baffle plate being driven laterally by a first baffle cylinder located outside the bottling box, the first baffle cylinder driving the first baffle plate through the first slot and into the bottling channel to receive taurine tablets.
[0008] Furthermore, each lozenge outlet has a second slot extending laterally on its upper sidewall; the second baffle assembly includes a second baffle plate that slides through the second slot, the second baffle plate being driven laterally by a second baffle cylinder located outside the bottling box, the second baffle cylinder driving the second baffle plate through the second slot and into the lozenge outlet to receive the taurine lozenge.
[0009] Furthermore, a tablet conveying mechanism is provided above the bottling box.
[0010] Furthermore, the lozenge conveying mechanism includes a first vibrating feeder, a second vibrating feeder, and a third vibrating feeder arranged laterally and sequentially from top to bottom. Each of the first, second, and third vibrating feeders has multiple longitudinally spaced feeding grooves, which are transversely connected and correspond to the positions of multiple lozenge drop inlets. A vibrator is provided at the bottom of each of the first, second, and third vibrating feeders.
[0011] Furthermore, a receiving surface is provided on the first vibrating feeder plate, the receiving surface is located next to the feeding groove, a tablet storage box is provided directly above the receiving surface, and a discharge port is provided at the bottom of the tablet storage box.
[0012] Compared with the prior art, the present invention has the following advantages: The present invention has a reasonable structural design, with multiple bottling channels and two tablet output ports. When one bottling channel or one tablet output port is blocked, other bottling channels and tablet output ports can be replaced for bottling operations without stopping the machine, ensuring continuous bottling operations and improving overall work efficiency. Attached Figure Description
[0013] Figure 1 This is a schematic diagram of the front cross-sectional structure of an embodiment of the present utility model;
[0014] Figure 2 This is a side view sectional structural diagram of an embodiment of the present utility model;
[0015] Figure 3 This is a top view of an embodiment of the present invention. Detailed Implementation
[0016] The present invention will now be described in further detail with reference to the accompanying drawings and specific embodiments.
[0017] In the description of this utility model, it should be understood that the terms "longitudinal", "lateral", "up", "down", "front", "back", "left", "right", "vertical", "horizontal", "top", "bottom", "inner", "outer", etc., indicate the orientation or positional relationship based on the orientation or positional relationship shown in the accompanying drawings. They are only for the convenience of describing this utility model and do not indicate or imply that the device or element referred to must have a specific orientation, or be constructed and operated in a specific orientation. Therefore, they should not be construed as limitations on this utility model.
[0018] like Figures 1-3 As shown, this utility model discloses a bottling structure for preparing taurine tablets, including a conveyor belt 1 for longitudinally conveying vertically placed packaging bottles 2. The packaging bottles are placed vertically on the conveyor belt, which conveys the bottles from front to back. A bottling box 3 is arranged directly above the conveyor belt 1. The bottling box 3 has multiple longitudinally arranged parallel bottling channels 4 inside, which are independent of each other and extend vertically. The top of the bottling box 3 has multiple tablet drop inlets 5 corresponding to the positions of the multiple bottling channels 4. The lozenge inlet 5 is connected to the corresponding bottling channel 4. The lozenge inlet facilitates the taurine lozenges falling into the bottling channel. Each bottling channel 4 has a first baffle assembly at its lower end, which is used to hold the taurine lozenges falling into the bottling channel. The lower end of the bottling box 3 has two longitudinally distributed lozenge outlets 6. Each lozenge outlet 6 is connected to several bottling channels 4 at the same time. Each lozenge outlet 6 has a second baffle assembly, which is used to hold the taurine lozenges falling into the lozenge outlet.
[0019] During operation, several taurine tablets fall into each bottling channel 4. The conveyor belt 1 transports the packaging bottle 2 directly below the tablet output port 6. The bottle mouth of the packaging bottle 2 is simultaneously aligned with the positions of two tablet output ports 6. Each time bottling occurs, the taurine tablets fall from only one of the tablet output ports 6. During bottling, the first baffle component in one of the bottling channels 4 opens, no longer holding the taurine tablets, and the taurine tablets in that bottling channel 4 fall into the tablet output port 6 connected to it, and from there into the packaging bottle 2. Then, the first baffle component in the next bottling channel 4 opens, and the taurine tablets in that bottling channel 4 fall into the tablet output port 6 connected to it. Then, the next bottling channel 4 performs the same operation, and so on, until all the taurine tablets in all the bottling channels connected to the tablet output port have fallen, thus completing the bottling operation. Since each bottling channel contains only a few taurine tablets, the limited quantity effectively prevents bottling channel blockage. Similarly, only one tablet from one bottling channel drops from the tablet output port at a time, also preventing blockage. When one tablet output port becomes blocked, the other tablet output port can be used directly, allowing for continuous bottling operations without stopping the machine.
[0020] In this embodiment, there are eight bottling channels 4, with four bottling channels 4 sharing one lozenge outlet 6 and the other four sharing another lozenge outlet 6. That is, each lozenge outlet is simultaneously connected to four bottling channels. It should be noted that the number of taurine lozenges in each bottling channel can be set as needed, for example, 5, 6, or 7 lozenges. Furthermore, each lozenge inlet is equipped with a counting sensor for counting the lozenges.
[0021] In this embodiment, in order to facilitate the sliding of taurine tablets, the lower end of the bottling box 3 is an inverted cone shape with a larger upper port diameter and a smaller lower port diameter. An output tube 7 is provided in the middle of the bottom surface of the bottling box 3, and two tablet output ports 6 are provided inside the output tube 7.
[0022] In this embodiment, each bottling channel 4 has a first slot extending laterally on its lower right side wall. The first baffle assembly includes a first baffle plate 8 that slides through the first slot. The first baffle plate 8 is driven laterally by a first baffle cylinder 9 located outside the bottling box 3. The first baffle cylinder 9 drives the first baffle plate 8 through the first slot and into the bottling channel 4 to receive and support the taurine tablets, preventing them from falling. When the first baffle cylinder drives the first baffle plate to extend, the taurine tablets can fall.
[0023] In this embodiment, each lozenge outlet 6 has a second slot extending laterally on its upper right side wall. The second baffle assembly includes a second baffle plate 10 that slides through the second slot. The second baffle plate 10 is driven laterally by a second baffle cylinder 11 located outside the bottling box 3. The second baffle cylinder 11 drives the second baffle plate 10 through the second slot and into the lozenge outlet 6 to receive and support the taurine lozenge, preventing it from falling. When the second baffle cylinder drives the second baffle plate to extend, the taurine lozenge can fall.
[0024] In this embodiment, a lozenge conveying mechanism 12 is provided above the bottling box 3. The lozenge conveying mechanism is used to convey the prepared taurine lozenges toward the lozenge drop inlet of the bottling box.
[0025] In this embodiment, the lozenge conveying mechanism 12 includes a first vibrating feeder 13, a second vibrating feeder 14, and a third vibrating feeder 15 distributed laterally from right to left. The first vibrating feeder 13, the second vibrating feeder 14, and the third vibrating feeder 15 are arranged sequentially from top to bottom. The right end of the second vibrating feeder 14 is located below the left end of the first vibrating feeder 13 to receive the taurine lozenges vibrated out by the first vibrating feeder 13. The second vibrating feeder 14 vibrates and conveys the taurine lozenges from right to left. The right end of the third vibrating feeder 15 is located below the left end of the second vibrating feeder 14 to receive the taurine lozenges vibrated out by the second vibrating feeder 14. The third vibrating feeder 15 vibrates and conveys the taurine lozenges from right to left. The left end of the third vibrating feeder 15 is located above the lozenge drop inlet 5 to facilitate the third vibrating feeder 15 conveying the taurine lozenges to the lozenge drop inlet 5.
[0026] In this embodiment, the first vibrating feeder 13, the second vibrating feeder 14, and the third vibrating feeder 15 are each provided with a plurality of longitudinally spaced feeding grooves 16. The feeding grooves on the first, second, and third vibrating feeders are directly opposite each other, and the feeding grooves 16 are transversely connected. The plurality of feeding grooves 16 correspond to the positions of the plurality of tablet drop inlets 5. The bottom of the first, second, and third vibrating feeders 13, 14, and 15 are each provided with a vibrator 17, which is used to apply vibration to achieve vibratory conveying. The three vibrating feeders cooperate to form a three-stage vibratory conveying system.
[0027] In this embodiment, a receiving surface 18 is provided on the first vibrating feeder 13. The receiving surface 18 is located on the right side of the feeding groove. A lozenge storage box 19 is provided directly above the receiving surface 18, and a discharge port is provided at the bottom of the lozenge storage box 19. During operation, the taurine lozenges in the lozenge storage box fall onto the receiving surface. Under the action of vibration, the taurine lozenges on the receiving surface fall into the feeding groove of the first vibrating feeder, and are then conveyed from right to left.
[0028] In this embodiment, protective baffles 20 are provided on both the left and right sides of the conveyor belt 1 to prevent the packaging bottles from tipping over to the left and right. A sensor 21 for detecting the packaging bottle 2 is provided on the protective baffle 20 on the right side. The sensor is positioned corresponding to the lozenge outlet. When the packaging bottle is conveyed to the sensor position by the conveyor belt, the sensor detects the packaging bottle and sends a signal to the controller, which then controls the conveyor belt to stop running. Preferably, the sensor can be an infrared sensor.
[0029] If this utility model discloses or relates to mutually fixedly connected parts or structural components, then, unless otherwise stated, a fixed connection can be understood as: a detachable fixed connection (e.g., using bolts or screws), or a non-detachable fixed connection (e.g., riveting, welding). Of course, mutually fixed connections can also be replaced by an integral structure (e.g., manufactured using a casting process) (except where it is obviously impossible to use an integral forming process).
[0030] In addition, unless otherwise stated, the terms used to indicate positional relationships or shapes in any of the technical solutions disclosed in this utility model above include states or shapes that are similar to, close to, or approximate with them.
[0031] Any component provided by this utility model can be assembled from multiple individual components, or it can be a single component manufactured by a one-piece molding process.
[0032] Finally, it should be noted that the above embodiments are only used to illustrate the technical solution of this utility model and not to limit it; although the utility model has been described in detail with reference to preferred embodiments, those skilled in the art should understand that modifications can still be made to the specific implementation of this utility model or equivalent substitutions can be made to some technical features without departing from the spirit of the technical solution of this utility model, and all such modifications and substitutions should be covered within the scope of the technical solution claimed by this utility model.
Claims
1. A bottling structure for the preparation of taurine tablets, comprising a conveyor belt for longitudinally conveying vertically placed packaging bottles, characterized in that: A bottling box is positioned directly above the conveyor belt. Inside the bottling box are multiple bottling channels arranged side-by-side along the longitudinal direction. The top of the bottling box has multiple lozenge drop inlets corresponding to the positions of the bottling channels. Each lozenge drop inlet is connected to the corresponding bottling channel. A first baffle assembly is provided at the lower end of each bottling channel. At the lower end of the bottling box are two lozenge output ports arranged along the longitudinal direction. Each lozenge output port is simultaneously connected to several bottling channels. A second baffle assembly is provided in each lozenge output port.
2. The bottling structure for preparing taurine tablets according to claim 1, characterized in that: The bottling channel has eight channels, four of which share one tablet output port, and the other four channels share another tablet output port.
3. The bottling structure for preparing taurine tablets according to claim 2, characterized in that: The lower end of the bottling box is inverted cone shape, and an output tube is provided in the middle of the bottom surface of the bottling box. Two tablet output ports are located inside the output tube.
4. The bottling structure for preparing taurine tablets according to claim 3, characterized in that: Each bottling channel has a first slot extending laterally on its lower sidewall; the first baffle assembly includes a first baffle plate that slides through the first slot. The first baffle plate is driven to move laterally by a first baffle cylinder located outside the bottling box. The first baffle cylinder drives the first baffle plate through the first slot and into the bottling channel to receive taurine tablets.
5. The bottling structure for preparing taurine tablets according to claim 4, characterized in that: Each lozenge outlet has a second slot extending laterally on its upper sidewall; the second baffle assembly includes a second baffle plate that slides through the second slot. The second baffle plate is driven laterally by a second baffle cylinder located outside the bottling box. The second baffle cylinder drives the second baffle plate through the second slot and into the lozenge outlet to receive the taurine lozenge.
6. The bottling structure for preparing taurine tablets according to claim 5, characterized in that: A tablet conveying mechanism is provided above the bottling box.
7. A bottling structure for preparing taurine tablets according to claim 6, characterized in that: The lozenge conveying mechanism includes a first vibrating feeder, a second vibrating feeder, and a third vibrating feeder arranged laterally and sequentially from top to bottom. Each of the first, second, and third vibrating feeders has multiple longitudinally spaced feeding grooves, which are transversely connected and correspond to the positions of multiple lozenge drop inlets. A vibrator is provided at the bottom of each of the first, second, and third vibrating feeders.
8. A bottling structure for preparing taurine tablets according to claim 7, characterized in that: The first vibrating feeder has a receiving surface on its upper part, which is located next to the feeding groove. A tablet storage box is located directly above the receiving surface, and a discharge port is located at the bottom of the tablet storage box.